EVERSANA Expands AI Platform Across Life Sciences Commercialization
EVERSANA is expanding its AI-powered commercialization platform beyond marketing, adding capabilities for medical affairs, market research, field sales and other functions across the pharmaceutical commercialization process. The move reflects a broader shift in life sciences AI adoption: companies are moving from isolated generative AI experiments toward connected workflows that can automate repetitive work while preserving…
